Celecoxib - Antiarthritic treatment of adenomatous polyposis COX-2 inhibitor

被引：0
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2001年 / 26卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：697 / 698
页数：2
相关论文
共 50 条
  • [21] A cox-2 inhibitor (celecoxib) as a possible adjunctive agent to expedite treatment response in bipolar depression
    Soares, Jair C.
    Nery, Fabiano G.
    Monkul, Emel S.
    Fonseca, Manoela
    Zunta, Giovana B.
    Frey, Benicio N.
    Hatch, John P.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S163 - S164
  • [22] Impact of the COX-2 selective inhibitor celecoxib on initiation and progression of atherosclerosis
    Metzner, J
    Manderscheid, C
    Popp, L
    Coste, O
    Geisslinger, G
    Niederberger, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 23 - 23
  • [23] DFT analysis and spectral characteristics of Celecoxib a potent COX-2 inhibitor
    Vijayakumar, B.
    Kannappan, V.
    Sathyanarayanamoorthi, V.
    JOURNAL OF MOLECULAR STRUCTURE, 2016, 1121 : 16 - 25
  • [24] Caution in using Celecoxib: Induction of VEGF and Angiogenesis by This COX-2 Inhibitor
    Shu, H.
    Gao, H.
    Xu, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S626 - S626
  • [25] Celecoxib: A specific COX-2 inhibitor with antiinflammatory, analgesic and anticancer activities
    Masferrer, JL
    Leahy, K
    Kobolt, C
    Perkins, W
    Zweifel, B
    Zhang, Y
    Koki, A
    Isakson, P
    Seibert, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R8 - R8
  • [26] Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC
    Srinivasu, MK
    Rao, DS
    Reddy, GO
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (3-4) : 493 - 500
  • [27] A randomized trial comparing ursodeoxycholic acid and rofecoxib, a selective COX-2 inhibitor, in the treatment of advanced duodenal adenomas in patients with familial adenomatous polyposis.
    Maclean, AR
    McLeod, RS
    Berk, T
    Gallinger, S
    GASTROENTEROLOGY, 2001, 120 (05) : A254 - A254
  • [28] A Double Bind Placebo Controlled Assessment of Mucosal Changes of the Duodenum in Patients with Familial Adenomatous Polyposis (FAP) After Treatment with a COX-2 Inhibitor (Rofecoxib)
    Aabakken, Lars
    Fausa, Olav
    Pascal, Ana Lobato
    Schjolberg, Aasa
    Andresen, Per Arne
    Grzyb, Krzysztof
    Larsen, Laila N.
    Vatn, Morten H.
    GASTROENTEROLOGY, 2009, 136 (05) : A451 - A451
  • [29] Retrospective clinical study of the efficacy of celecoxib, a COX-2 inhibitor, in the treatment of COVID-19 pneumonia
    Wang, Hailong
    Yu, Shimei
    RESPIROLOGY, 2023, 28 : 34 - 35
  • [30] Application of light emitting diode and Celecoxib (Cox-2 inhibitor) for the management of wounds
    Thng, S. T.
    Manoj, K.
    Tan, M.
    Chow, P.
    Moochhala, S. M.
    Lu, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 : S135 - S135
12345